Fineotex Chemical Q3 FY2025-2026 results highlight growth, acquisition, and capital actions driving performance

Fineotex Chemical reported strong Q3 FY 2025-2026 numbers, highlighting solid growth, better margins, and active capital actions. The quarter ended 31 December 2025 also showed progress in global expansion, with a new overseas acquisition and continued interest from investors reflected in warrant conversions and shareholding patterns.

The latest board meeting on 13 February 2026 reviewed these Q3 figures and strategic steps. Management reported healthy revenue expansion, higher profits, and improved returns on capital, along with changes to share capital structure through a split and a sizeable bonus issue to shareholders.

On a consolidated quarter-on-quarter basis, revenue from operations increased 30.96%, rising from Rs. 14,543 lakhs to Rs. 19,046 lakhs. Consolidated profit after tax moved up 15.50%, climbing from Rs. 2,608 lakhs to Rs. 3,012 lakhs. Operational EBITDA advanced 12.28% during the same period, going from Rs. 3,103 lakhs to Rs. 3,484 lakhs, signalling better operating efficiency.

Comparing year-on-year performance for Q3 FY 2025-2026, Fineotex Chemical also delivered strong topline momentum. Revenue from operations grew 45.49%, increasing from Rs. 13,091 lakhs in the earlier year’s corresponding quarter to Rs. 19,046 lakhs. Profit after tax for the quarter stood at Rs. 3,012 lakhs, which is 8.23% higher than Rs. 2,783 lakhs a year ago.

The company’s capital efficiency metrics remained robust through this growth phase. For Q3 FYE 2026, Fineotex Chemical reported a consolidated Return on Invested Capital of 26.82%. This level indicates that recent capacity, technology, and market investments are generating healthy returns relative to the capital deployed across operations.

Key quarterly financial information for Fineotex Chemical, both quarter-on-quarter and year-on-year, is summarised below for clarity. The table captures movements in revenue, profit after tax, and operational EBITDA, highlighting the strength of operational performance during the quarter ended 31 December 2025.

Metric	Q3 FY 2025-2026	Q2 FY 2025-2026	Q3 FY 2024-2025	Change Q-o-Q	Change Y-o-Y
Revenue from operations (Rs. lakhs)	19,046	14,543	13,091	+30.96%	+45.49%
Profit after tax (Rs. lakhs)	3,012	2,608	2,783	+15.50%	+8.23%
Operational EBITDA (Rs. lakhs)	3,484	3,103	NA	+12.28%	NA

Fineotex Chemical Q3 FY 2025-2026 results and global acquisition move

During Q3, Fineotex Chemical advanced its international strategy by acquiring CrudeChem Technologies through a subsidiary. CrudeChem Technologies, based in the United States, manufactures specialty chemicals and offers complete oilfield chemical solutions, along with advanced chemical fluid additives, catering to oil and gas customers across global markets.

This acquisition is described by the company as a key stage in expanding its international presence. The deal is expected to enhance Fineotex Chemical’s technical capabilities and strengthen its position in high-performance and environmentally focused chemical solutions, supporting long-term growth plans in energy-related and specialty chemical segments.

Funding activity also remained visible in the quarter. Fineotex Chemical received about Rs. 35.68 crores from subscription money, driven by the conversion of 75% of outstanding warrants. Out of these, the promoter converted 5,00,000 warrants, bringing in Rs. 17.30 crores, at an implied issue price of around Rs. 346 per share before corporate actions.

After accounting for the later share split and bonus, the effective price linked to those warrants works out to Rs. 34.60 per share. The warrant conversions increased paid-up capital while signalling promoter confidence in the company’s future earnings potential, given the sizeable personal capital commitment during the quarter.

Fineotex Chemical Q3 FY 2025-2026 results, share split, and bonus actions

Fineotex Chemical also restructured its equity share capital during the period under review. On 27 September 2025, the Board approved a sub-division of equity shares from face value Rs. 2 each, fully paid, into equity shares of face value Rs. 1 each, fully paid, effective for the quarter ended 31 December 2025.

Following this share split, the authorised capital changed accordingly. It moved from 60,00,00,000 equity shares of Rs. 2 each to 120,00,00,000 equity shares of Rs. 1 each. This step provided additional flexibility for future equity issuances, while lowering the nominal face value per share for existing and prospective investors.

Shareholders also approved a bonus issue in the ratio of 4:1. For every one fully paid equity share of Rs. 1 held as on the record date, investors received four additional equity shares of Rs. 1. On 31 October 2025, Fineotex Chemical allotted 91,66,00,720 bonus equity shares, using the share premium balance for this capitalisation.

These corporate actions collectively increased the number of outstanding shares and may have improved secondary market liquidity. At the same time, they did not alter the overall equity value but redistributed it over a larger share base, which is common practice among listed Indian companies seeking broader retail participation.

On the market side, the Fineotex Chemical share price showed modest gains during the latest trading session referenced. On 13 February 2026, the stock closed at Rs. 24.05 on the NSE and Rs. 24.09 on the BSE, implying an intraday rise of about 0.46% to 0.67% compared with the previous close.

Institutional and well-known investors have remained present in the shareholding structure. As of the December 2025 quarter, seasoned investor Ashish Kacholia held a 2.58% stake in Fineotex Chemical. Together with the strong Q3 FY 2025-2026 results, this combination of performance, capital restructuring, and investor interest outlines a company focused on growth and operational discipline.